DAB(389)-interleukin 2

Known as: DAB389IL2, DAB(389)IL-2, DAB(389)-Interleukin-2 
 

Topic mentions per year

Topic mentions per year

1991-2017
01219912017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Activated T cells express the high affinity interleukin 2 receptor (IL-2R also CD25) that binds interleukin 2 (IL-2) and… (More)
Is this relevant?
2003
2003
The novel fusion protein DT388IL3, composed of the catalytic and translocation domains of diphtheria toxin (DT388) fused with a… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
2002
2002
DAB(389)IL-2 (ONTAK) is a fusion protein consisting of the ADP-ribosyltransferase and membrane translocating domains of native… (More)
Is this relevant?
2001
2001
BACKGROUND Denileukin diftitox, a fusion protein targeting both malignant and normal activated lymphocytes, has been shown… (More)
Is this relevant?
1998
1998
The purpose of this study was to evaluate the safety, tolerability, pharmacokinetics, and possible antitumor activity of a ligand… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
1998
1998
BACKGROUND DAB389IL-2 is a novel fusion toxin that retargets the cytotoxic A-chain of diphtheria toxin to interleukin-2 (IL-2… (More)
Is this relevant?
1998
1998
Four patients with late stage cutaneous T cell lymphoma (IB-IVA) who had failed at least two previous therapies were treated with… (More)
Is this relevant?
1998
1998
BACKGROUND Current therapies for recalcitrant psoriasis focus on immunoregulation and targeting of activated T-lymphocytes rather… (More)
Is this relevant?
1998
1998
We examined the effects of CTLA4Ig treatment in an experimental model of myasthenia gravis (EAMG) induced by immunizing Lewis… (More)
Is this relevant?